| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 3,490 | $10 | $45.3K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 830 | $50 | $38.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 610 | $60 | $35K |
| J0897 | Injection, denosumab, 1 mg | 1,680 | $20 | $30.2K |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 4,030 | $10 | $28.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 220 | $80 | $17.7K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 20 | $560 | $9.5K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 90 | $100 | $8.8K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 160 | $30 | $5.1K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 80 | $60 | $4.6K |